Announcements Trials
Browse Landscape

Phase

Phase NA 2Phase 4 1

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3NET 1Endocrine 1

Conditions

Pancreatic Neoplasms 3Neoplasms 2Sarcoidosis 1Prostatic Neoplasms 1Prostatic Hyperplasia 1Pancreatic Diseases 1Pancreatic Cyst 1Neuroendocrine Tumors 1Neoplastic Cells, Circulating 1Lymphoma, Follicular 1Lymphoma 1Lymphadenopathy 1Lung Neoplasms 1Disease 1

Interventions

Gemcitabine 679130-nm albumin-bound paclitaxel 198Fluorouracil 186Oxaliplatin 175Albumin-Bound Paclitaxel 151Capecitabine 137Leucovorin 131Irinotecan 113Radiotherapy 95Taxes 83pembrolizumab 80Cisplatin 72Erlotinib Hydrochloride 69Radiosurgery 67Nivolumab 56Bevacizumab 54Drug Therapy 52Cyclophosphamide 49Magnetic Resonance Spectroscopy 46folfirinox 42Docetaxel 41Cetuximab 40Specimen Handling 37irinotecan sucrosofate 36S 1 (combination) 36Biopsy 31Radiation 29Paclitaxel 29Ipilimumab 27durvalumab 26

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Interventional × Pancreatic Neoplasms × Needles × Clear all
NCT00548626 2015-12-21

EMUNE-07

University of Chicago

Phase NA Completed
47 enrolled
Gastrointestinal

Pancreatic Neoplasms

NCT02092519 2015-07-29

RCT: Difference in Diagnostic Yield Between EUSFNA Needles With and Without a Side Port in Pancreatic Masses

Changi General Hospital

Phase 4 Completed
40 enrolled
Gastrointestinal

Pancreatic Diseases, Pancreatic Neoplasms

NCT02246322 2014-09-22

EUS-FNA

Istituto Clinico Humanitas

Phase NA Unknown
144 enrolled
EndocrineGastrointestinalNET

Lymphadenopathy, Pancreatic Neoplasms, Neuroendocrine Tumors

Data powered by HemOnc (CC BY 4.0) Colophon âš¡